Validations: Biologics, ATMP & Viral Safety Validation
Governance for ATMP Validation across Sites Introduction to Advanced Therapy Medicinal Products (ATMP) Advanced Therapy Medicinal Products (ATMPs) represent a transformative class of therapies that include gene therapy, somatic cell therapy, and tissue-engineered products. With their complex nature, the validation processes for ATMPs are critical to ensure safety, efficacy, and compliance with regulatory expectations laid out by authorities like the…
Training for ATMP PPQ/CPV Teams Training for ATMP PPQ/CPV Teams The biopharmaceutical industry faces increasingly complex challenges when developing advanced therapy medicinal products (ATMPs). As regulatory expectations evolve, the emphasis on robust process validation, specifically regarding performance qualification (PPQ) and continued process verification (CPV), has become paramount. This article serves as a comprehensive guide for professionals involved in ATMP PPQ…
Bridging Across Indications/Products in Biologics and ATMP Validation The landscape of biologics and advanced therapy medicinal products (ATMPs) validation poses intricate challenges, particularly in the areas of process performance qualification (PPQ) and continued process verification (CPV). This article serves as a comprehensive step-by-step tutorial, tailored for pharmaceutical professionals, regulatory affairs, and clinical operations personnel engaged in the validation of ATMPs,…
KPI Sets for ATMP PPQ/CPV Advanced Therapy Medicinal Products (ATMPs) represent a significant evolution in the field of biologics. With the complexities involved in their production and validation, it is essential to establish key performance indicators (KPIs) for Process Performance Qualification (PPQ) and continued process verification (CPV). This article serves as a comprehensive guide for pharmaceutical professionals engaged in validating…
Small-Scale Models for ATMP Validation Small-Scale Models for ATMP Validation Advanced Therapy Medicinal Products (ATMPs) represent a groundbreaking shift in biopharmaceuticals. Their complexity requires a nuanced approach to validation, particularly in the context of Process Performance Qualification (PPQ) and Contingent Process Validation (CPV). This article will guide you through the step-by-step processes of utilizing small-scale models for ATMP validation, focusing…
Storyboards for ATMP PPQ/CPV in Inspections Storyboards for ATMP PPQ/CPV in Inspections In the ever-evolving landscape of advanced therapy medicinal products (ATMP), ensuring compliance with regulatory expectations is paramount. This article serves as a detailed tutorial on the development and implementation of storyboards tailored for the Process Performance Qualification (PPQ) and Continued Process Verification (CPV) of ATMPs during regulatory inspections….
Interventions & Changes: Verification vs Re-Validation Introduction to Validation in Biologics and ATMP The validation of biologics and Advanced Therapy Medicinal Products (ATMP) plays a critical role within the pharmaceutical industry, especially in the context of current Good Manufacturing Practices (cGMP). This validation process ensures that the production methods and controls meet regulatory expectations as set forth by agencies such…
Digital Dashboards for ATMP CPV Digital Dashboards for ATMP CPV: A Comprehensive Guide Understanding Advanced Therapy Medicinal Products (ATMP) Advanced therapy medicinal products (ATMPs) include gene therapies, somatic cell therapies, and tissue-engineered products. These innovative biopharmaceuticals offer new treatment avenues for complex diseases, including genetic disorders and cancer. Therefore, ATMPs require stringent validation processes to ensure safety, efficacy, and compliance…
Common ATMP PPQ/CPV Gaps—and Fixes Identifying and Addressing Common ATMP PPQ/CPV Gaps Introduction to PPQ and CPV in Advanced Therapy Medicinal Products (ATMP) Advanced Therapy Medicinal Products (ATMP) represent a complex and rapidly evolving class of pharmaceuticals that include gene therapies, somatic cell therapies, and tissue-engineered products. Given their unique characteristics, validation of these products through Process Performance Qualification (PPQ)…
Common ATMP PPQ/CPV Gaps—and Fixes The biologics sector, particularly in advanced therapy medicinal products (ATMP), is under increasing scrutiny to ensure robust process validation and control. As pharmaceutical professionals strive to meet the expectations set by regulatory authorities such as the FDA, EMA, and MHRA, it becomes vital to address common gaps in Process Performance Qualification (PPQ) and Continued Process…